#NASH

But a simple improvement in dietary intake reversed fatty liver disease and staved off cancer.

Sintilimab plus chemotherapy infused into a liver artery may offer the chance for a cure.

A companion study will look at liver biopsy results to confirm these findings from noninvasive tests.

Excess weight, which is often linked to metabolic abnormalities, can contribute to a wide variety of health problems.

People with NAFLD have an elevated risk of cancer, largely due to high liver cancer incidence.

The disease has similar prevalence across high-income and low- and middle-income nations.

Unexpectedly, liver steatosis was also associated with a greater chance of achieving HBsAg seroclearance.

The diabetes medication, alone or in combination regimens, led to improvements in NASH and fibrosis.

A Mediterranean diet could help reduce the risk of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Developing treatments for fatty liver disease has proved challenging, and there are currently no approved medications.

Optimal treatment for fatty liver disease may involve combining drugs with different mechanisms of action.

The best-performing combo, firsocostat and cilofexor, showed benefits despite missing the main study endpoint.

Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.

People with advanced liver cirrhosis are at greater risk for severe COVID-19 illness and death.

Researchers reported significant changes in liver, cardiovascular and diabetes markers.

The regulatory agency requested further data to show whether its benefits outweigh its risks.